Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 2, 2023
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
[ Thu, Nov 02nd 2023
] - WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy with Decreased Target to $49 on, Nov 2nd, 2023
Mike Matson of Needham, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Decreased Target from $68 to $49 on, Nov 2nd, 2023.
Mike has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 0 agree with Mike's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mike
- Daniel Stauder of "JMP Securities" Initiated at Buy and Held Target at $60 on, Monday, October 23rd, 2023
- Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $56 on, Friday, September 29th, 2023
